Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Aurora Cannabis Inc T.ACB

Alternate Symbol(s):  T.ACB.WS.U | ACB

Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company's principal business lines are focused on the production, distribution, and sale of cannabis related products in Canada and internationally. The Company’s segments include Canadian Cannabis, European Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being and Greybeard, as well as CBD brands, Reliva and KG7. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol and CraftPlant. Its cannabis products are primarily cultivated and manufactured in the facilities in Edmonton, Alberta; Bradford Ontario; Pemberton, British Columbia, and Odense, Denmark. The Company is focused on offering its cannabis products to global medical cannabis market, recreational cannabis market and global hemp-derived cannabidiol (CBD) markets.


TSX:ACB - Post by User

Bullboard Posts
Comment by longonMJon May 19, 2019 1:49pm
77 Views
Post# 29759717

RE:IN DO TIME AURORA WILL CRUSH CANOPY GROWTH LIKE A TOMATO

RE:IN DO TIME AURORA WILL CRUSH CANOPY GROWTH LIKE A TOMATO
mozzarella wrote:

Pretty much everything seems to be going right for Aurora Cannabis these days. Aurora beat revenue expectations in its latest quarter. 



The future definitely looks green and up for Aurora going forward.

Unfortuantely, when the writer starts off his article with an obviously incorrect statement, readers just might question the integrity for what is written in the rest of his article.  As everybody knows, Aurora clearly missed both the top line and the bottom line expectations for this 3rd quarter.

I believe revenue expectations for Aurora was in the high $60M's to mid $70M's after being reduced from something like $91M earlier in the quarter due to all of the supply chain management issues affecting all of the companies.  So, to say that ACB beat revenue expectations is clearly disingenuous and a huge stretch on the writer's part whihc kind of puts the rest of his article into question.

Bullboard Posts